Schedule 13D ownership disclosure

BELLICUM PHARMACEUTICALS INC

Security class unavailable · CUSIP: 079481107

Event date: 2017-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,032,313
Percent of class
15.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-017097
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Mar 28, 2017
Reporting period
Mar 23, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub